Last Updated: May 3, 2026

Litigation Details for AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC (D. Del. 2016)


✉ Email this page to a colleague

« Back to Dashboard


AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC (D. Del. 2016)

Docket 1:16-cv-00669 Date Filed 2016-08-05
Court District Court, D. Delaware Date Terminated 2016-11-04
Cause 35:0145 Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Patents 6,774,122; 7,456,160; 8,329,680; 8,466,139
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC
The small molecule drug covered by the patents cited in this case is ⤷  Start Trial .

Details for AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-08-05 External link to document
2016-08-05 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,122; 7,456,160; 8,329,680…2016 4 November 2016 1:16-cv-00669 830 Patent None District Court, D. Delaware External link to document
2016-08-05 8 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,122; 7,456,160; 8,329,680…2016 4 November 2016 1:16-cv-00669 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.